Rasilez New Zealand - English - Medsafe (Medicines Safety Authority)

rasilez

novartis new zealand ltd - aliskiren hemifumarate 165.75mg equivalent to 150 mg aliskiren;  ;   - film coated tablet - 150 mg - active: aliskiren hemifumarate 165.75mg equivalent to 150 mg aliskiren     excipient: colloidal silicon dioxide crospovidone basic coating premix white basic coating premix red basic coating premix black magnesium stearate microcrystalline cellulose povidone - rasilez is indicated for the treatment of hypertension.

Rasilez New Zealand - English - Medsafe (Medicines Safety Authority)

rasilez

novartis new zealand ltd - aliskiren hemifumarate 331.5mg equivalent to 300 mg aliskiren;  ;   - film coated tablet - 300 mg - active: aliskiren hemifumarate 331.5mg equivalent to 300 mg aliskiren     excipient: colloidal silicon dioxide crospovidone basic coating premix white basic coating premix red basic coating premix black magnesium stearate microcrystalline cellulose povidone - rasilez is indicated for the treatment of hypertension.

Rasilez Film Coated Tablet 150mg Singapore - English - HSA (Health Sciences Authority)

rasilez film coated tablet 150mg

novartis (singapore) pte ltd - aliskiren - tablet, film coated - 150mg

Rasilez Film Coated Tablet 300mg Singapore - English - HSA (Health Sciences Authority)

rasilez film coated tablet 300mg

novartis (singapore) pte ltd - aliskiren - tablet, film coated - 300mg

RASILEZ 150 MG Israel - English - Ministry of Health

rasilez 150 mg

novartis pharma services ag - aliskiren 150 mg - film coated tablets - aliskiren - treatment of essential hypertension.

RASILEZ 300 MG Israel - English - Ministry of Health

rasilez 300 mg

novartis pharma services ag - aliskiren 300 mg - film coated tablets - aliskiren - treatment of essential hypertension.